论文部分内容阅读
乙型肝炎是严重威胁人民健康,发病率很高的一种传染病。该病病程迁延,易转变为慢性活动性肝炎、肝硬变及肝癌。过去治疗乙肝的药物效果不很理想,且均属非特异性制剂。最近,位于成都市电信路19号的四川卫生保健科技研究服务部,引进了吉林省辉南生物化学制药厂研制的“抗乙肝免疫核糖核酸”注射液,这种新药经临床应用,治乙肝效果显著,具有预防和治疗乙肝的双重功能,能有效地消除乙肝病毒或促进乙肝病毒抗体形成,恢复肝脏功能,老少及孕妇均可应用。
Hepatitis B is a kind of infectious disease with serious threat to people’s health and high incidence. Prolonged course of the disease, easy to change into chronic active hepatitis, cirrhosis and liver cancer. The past treatment of hepatitis B drug effect is not very satisfactory, and are non-specific preparations. Recently, Sichuan Health Science and Technology Research Service Department, located at Telecom Road No. 19 in Chengdu, introduced the “anti-hepatitis B immune RNase” injection developed by Huinan Biochemical Pharmaceutical Factory in Jilin Province. The new drug has been clinically applied to treat hepatitis B Significantly, with the dual function of prevention and treatment of hepatitis B, can effectively eliminate or promote the formation of hepatitis B virus antibodies, liver function recovery, young and pregnant women can be applied.